Skip to main content
Article
International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries
Cancer Epidemiology
  • Valerie A. McCormacka, International Agency for Research on Cancer
  • Anya Burton, International Agency for Research on Cancer
  • Isabel dos-Santos-Silva, London School of Hygiene and Tropical Medicine
  • John H. Hipwell, University College London
  • Caroline Dickens, University of the Witwatersrand
  • Dorria Salem, Cairo University
  • Rasha Kama, Cairo University Hospitals
  • Mikael Hartman, National University of Singapore
  • Charmaine Pei Ling Lee, National University of Singapore
  • Kee-Seng Chia, National University of Singapore
  • Vahit Ozmen, Istanbul University
  • Mustafa Erkin Aribal, Istanbul University
  • Anath Arzee Flugelman, National Cancer Control Center, Israel
  • Martín Lajous, Chan School of Public Health
  • Ruy Lopez-Riduara, Instituto Nacional de Salud Pública
  • Megan Rice, Brigham and Women’s Hospital
  • Isabelle Romieu, International Agency for Research on Cancer
  • Giske Ursin, Cancer Registry of Norway
  • Samera Qureshi, Norwegian Center for Minority Health Research
  • Huiyan Ma, Beckman Research Institute
  • Eunjung Lee, University of Southern California
  • Carla H. van Gils, University Medical Center Utrecht
  • Johanna O.P. Wanders, University Medical Center Utrecht
  • Sudhir Vinayak, Aga Khan University
  • Rose Ndumia, Aga Khan University
  • Steve Allen, Royal Marsden NHS Foundation Trust
  • Sarah Vinnicombe, Ninewells Hospital & Medical School
  • Sue Moss, Queen Mary University of London
  • Jong Won Lee, Asan Medical Center
  • Jisun Kim, Asan Medical Center
  • Ana Pereira, University of Chile
  • Maria Luisa Garmendia, University of Chile
  • Reza Sirous, Isfahan University of Medical Sciences
  • Mehri Sirous, Isfahan University of Medical Sciences
  • Beata Peplonska, Nofer Institute of Occupational Medicine
  • Agnieszka Bukowska, Nofer Institute of Occupational Medicine
  • Rulla M. Tamimi, Harvard Medical School
  • Kimberly Bertrand, Boston University
  • Chisato Nagata, Gifu University
  • Ava Kwong, The University of Hong Kong
  • Celine Vachon, Mayo Clinic, Rochester
  • Christopher Scott, Mayo Clinic, Rochester
  • Beatriz Perez-Gomez, Instituto de Salud Carlos III and CIBERESP
  • Marina Pollan, Instituto de Salud Carlos III and CIBERESP
  • Gertraud Maskarinec, University of Hawaii Cancer Center
  • Graham Giles, Istanbul University
  • John Hopper, I Cancer Epidemiology Centre
  • Jennifer Stone, University of Western Australia
  • Nadia Rajaram, University Malaya
  • Soo-Hwang Teo, University Malaya
  • Shivaani Mariapun, University Malaya
  • Martin J. Yaffe, University of Toronto
  • Joachim Schüz, International Agency for Research on Cancer
  • Anna M. Chiarelli, Cancer Care Ontario
  • Linda Linton, Princess Margaret Cancer Centre
  • Norman F. Boyd, Princess Margaret Cancer Centre
Publication Date
1-1-2016
Document Type
Article
Disciplines
Abstract
Mammographic density (MD) is a quantitative trait, measurable in all women, and is among the strongest markers of breast cancer risk. The population-based epidemiology of MD has revealed genetic, lifestyle and societal/environmental determinants, but studies have largely been conducted in women with similar westernized lifestyles living in countries with high breast cancer incidence rates. To benefit from the heterogeneity in risk factors and their combinations worldwide, we created an International Consortium on Mammographic Density (ICMD) to pool individual-level epidemiological and MD data from general population studies worldwide. ICMD aims to characterize determinants of MD more precisely, and to evaluate whether they are consistent across populations worldwide. We included 11755 women, from 27 studies in 22 countries, on whom individual-level risk factor data were pooled and original mammographic images were re-read for ICMD to obtain standardized comparable MD data. In the present article, we present (i) the rationale for this consortium; (ii) characteristics of the studies and women included; and (iii) study methodology to obtain comparable MD data from original re-read films. We also highlightthe risk factor heterogeneity captured by such an effort and, thus,the unique insightthe pooled study promises to offer through wider exposure ranges, different confounding structures and enhanced power for sub-group analyses.
Citation Information
Valerie A. McCormacka, Anya Burton, Isabel dos-Santos-Silva, John H. Hipwell, et al.. "International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries" Cancer Epidemiology Vol. 40 (2016) p. 141 - 151
Available at: http://works.bepress.com/m-chiarelli/9/